Related Experiment Video
Updated: May 1, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Current concepts about inhibition of platelet aggregation
Giovanni de Gaetano1, Marilena Crescente, Chiara Cerletti
1Research Laboratories, Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy. gdegaetano@rm.unicatt.it
Platelet function tests revolutionized cardiovascular disease treatment but lack standardized methods. Their clinical validity in monitoring antiplatelet drug response remains unproven due to contradictory data.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Clinical Pathology
Background:
- Antiplatelet therapy has transformed cardiovascular disease treatment.
- Platelet function testing, since 1962, aids in diagnosing bleeding disorders and researching platelet reactivity.
- Current applications focus on assessing antiplatelet drug efficacy in thrombotic disorders.
Purpose of the Study:
- To review the current status and clinical validity of platelet function testing.
- To highlight the challenges and inconsistencies in applying these tests for monitoring antiplatelet therapy.
Main Methods:
- Review of historical development of platelet function testing.
- Analysis of current methodologies and their application in clinical practice.
- Evaluation of existing literature on the efficacy and limitations of platelet function tests.
Main Results:
- Platelet function tests have evolved significantly since their inception.
- Despite widespread use, significant contradictions and lack of standardization exist in methodologies.
- Clinical validity for monitoring antiplatelet drug efficacy is not yet established.
Conclusions:
- While platelet function tests are valuable research tools, their clinical application in monitoring antiplatelet therapy is hampered by methodological inconsistencies.
- Further standardization and validation are required to establish the clinical utility of these tests in thrombotic disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis

